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Autophagy undergoes a fine tuning during tissue differentiation and organ remodeling
in order to meet the dynamic changes in the metabolic needs. While the involvement
of autophagy in the homeostasis of mature muscle tissues has been intensively
studied, no study has so far addressed the regulation of autophagy in relation to the
metabolic state during the myogenic differentiation. In our recently published study
(Fortini et al., 2016) we investigated the metabolic profile and regulation of autophagy
that accompany the differentiation process of mouse skeletal muscle satellite cells
(MSC)-derived myoblasts into myotubes. Here, we briefly present these findings also
in the light of similar studies conducted by other authors. We show that during myogenic
differentiation mitochondrial function and activity are greatly increased, and the activation
of autophagy accompanies the transition from myoblasts to myotube. Autophagy is
mTORC1 inactivation-independent and, remarkably, is required to allow the myocyte
fusion process, as shown by impaired cell fusion when the autophagic flux is inhibited
either by genetic or drug manipulation. Further, we found that myoblasts derived
from p53 null mice show defective terminal differentiation into myotubes and reduced
activation of basal autophagy. Of note, glycolysis prevails and mitochondrial biogenesis
is strongly impaired in p53-null myoblasts. Thus, autophagy, mitochondrial homeostasis,
and differentiation are finely tuned in a coordinate manner during muscle biogenesis.
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Muscle cell differentiation involves significant gene reprogramming as well as cellular reshaping.
The role and modulation of autophagy in muscle in several physiological and pathological
conditions, including fasting, atrophy and exercise, have been deeply investigated (Vainshtein
et al., 2014), but the functional relationship between autophagy and cell metabolism during muscle
differentiation remains largely obscure.
Here we illustrate the main findings reported in our recently published paper (Fortini
et al., 2016) where we exploited the ability of mouse skeletal Muscle Satellite Cells
(MSC)-derived myoblasts to differentiate into myotubes to study the integrated network
that cross-regulates autophagy metabolism reprogramming during myogenesis. The forkhead
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box O3 (FoxO3) transcription factor FoxO3, which is
induced by oxidative stress (Li et al., 2015) and in atrophic
skeletal muscle (Mammucari et al., 2007), is known to control
the transcription of autophagy-related genes, including LC3.
Consistently, we found that the mRNA level of FoxO3 and
of LC3 increased up to three- and four-folds, respectively,
during the transition from myoblast to myotube. Western
blotting and immunofluorescence confirmed that autophagy was
up-regulated soon after the MSC myoblasts were induced to
differentiate into myocytes, and remained up-regulated during
the fusion process leading to myotubes. Yet, the net production
of autophagosomes slightly decreased in fully differentiated
myotubes. Up-regulation of autophagy during the differentiation
of myoblasts through the formation of mature myotubes has
been also reported by Gottlieb and associates (Sin et al.,
2016).
Macromolecular turnover is a requisite of the myogenic
program. Consistent with this view, autophagy was not up-
regulated in myocytes that were cultured at very low density,
a condition that does not allow their fusion into myotubes.
To further confirm the important role of autophagy in the
myogenesis, we used two different approaches to prevent
the induction of autophagy in MSC myoblasts, namely the
presence of the antioxidant N-acetyl cysteine (NAC) during
differentiation and the post-transcriptional silencing of Beclin
1. NAC has been shown to significantly decrease the basal
autophagic flux in skeletal muscles of mice by limiting
the production of reactive oxygen species (Rahman et al.,
2014). Both these treatments effectively hampered the up-
regulation of autophagy, and concomitantly we observed a
remarkable reduction of the fusion index (by approximately
two-folds).
mTORC1, a negative regulator of autophagy, plays a pivotal
role in muscle biogenesis, as it controls multiple stages of the
myofiber formation process (Erbay et al., 2003; Sun et al.,
2010). Remarkably, mTORC1 remained active during the whole
process of differentiation up to the myotube formation, and
in spite of this autophagy was induced. Since the AMPk
pathway was concomitantly induced along the myogenesis
process, we speculate that AMPk overrides the mTOR inhibitory
action gradually with time so that autophagy was modulated
in a fashion compatible with the differentiation and fusion
processes.
The inhibition of mTORC1 by rapamycin led to a further
stimulation of autophagy, indicating that mTORC1 exerts a tonic
inhibition on autophagy during the process. When the myoblasts
were treated with rapamycin myotube formation was drastically
impaired. The picture that emerges is that autophagy must be
finely tuned and balanced in coordination with cell metabolism
in order to allow the correct development of the skeletal muscle
tissue.
The metabolic reprogramming during myogenesis was
therefore studied in the same cell system. Interestingly, the
transcription of PGC-1α, a master regulator of mitochondrial
biogenesis, but not of PGC1α, was significantly up-regulated
during muscle differentiation, and in parallel the number
of mitochondrial DNA molecules as well as the levels of
mitochondrial proteins also increased. The production of
ATP+ADP, but not that of lactate, also increased during the
myogenic process. These data are supportive of an increased
mitochondrial activity in the passage from undifferentiated
myoblasts to mature myotube. This is consistent with
the recent findings reported by Sin et al. (2016) who
additionally showed that a dynamic remodeling of the
mitochondrial network, including mitochondrial clearance
and biogenesis, is required during the myoblast/myotube
transition (Figure 1). This mitochondrial remodeling
was impaired when autophagy was blocked (Sin et al.,
2016).
To get a more in depth insight into the mechanistic
relationship between cell metabolism reprogramming,
mitochondrial homeostasis and autophagy in the myogenic
process, we performed a similar study in p53-null MSC-derived
myoblasts cultivated under differentiation permissive conditions.
In fact, p53 is known to affect myoblast differentiation (Porrello
et al., 2000; Cam et al., 2006) and muscle metabolism (Park
et al., 2009; Saleem et al., 2014), as well as autophagy (Maiuri
et al., 2010; Rufini et al., 2013). Consistent with previous
findings (Porrello et al., 2000; Fortini et al., 2012), the formation
of myotubes was impaired in p53-null myoblasts, and in
parallel we found that the induction of autophagy during the
incubation in the differentiation condition was attenuated.
Indeed, p53-null myoblasts showed abnormalities in the
lysosomal apparatus that reflected in the reduced formation
of autolysosomes. In contrast to what observed in p53-
proficient myoblasts, in which the glycolytic rate did not
change during myogenesis, in p53-null myoblasts an increased
glycolytic flux occurred during their differentiation, as testified
by the concurrent increase in lactate and in ATP+ADP.
Further, in p53-null myoblasts, the mRNA level of PGC-1α
remained unchanged, and the content of mtDNA, as well as
the protein levels of COXIV and OXPHOS, did not increase
in the course of differentiation. It is of note that p53 KO
mice show greater fatigability and less locomotory endurance
than wild-type animals, and this is associated with reduced
expression of PGC-1α and diminished mitochondrial content
and functionality in the gastrocnemius (Saleem et al., 2014)
providing clear evidence that mitochondrial biogenesis and
muscle performance are causally associated. We hypothesize
that imperfect myogenesis in these cells could arise from
impaired mitophagy. In fact, we observed that abnormal
mitochondria forming aggregates accumulated in p53 null
myoblasts.
In conclusion, we (Fortini et al., 2016) and others (Sin
et al., 2016) demonstrated that the correct execution of the
myogenesis program requires the concurrent and coordinated
modulation of autophagy, cell metabolism, and mitochondrial
remodeling. Further, we demonstrated that the lack of p53
attenuated autophagy and mitogenesis, caused the switch from
aerobic respiration to glycolysis, and impaired myogenesis, thus
highlighting the role of physiological p53 activity for muscle
homeostasis (Fortini et al., 2016). The link between p53, oxidative
stress, FoxO3, autophagy and mitogenesis during myogenesis
clearly deserves a more in depth analysis. In this respect,
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FIGURE 1 | Coordinated metabolic changes and modulation of autophagy during myoblasts differentiation and fusion into myotubes. In p53-proficient
MSC-derived myoblasts, autophagy and mitophagy are activated, increase along with the differentiation of myoblasts into myocytes and continue to increase up to
the step of cell-to-cell fusion. Once the myotubes have formed, autophagy and mitophagy gradually slow-down to the basal level. The remodeling of the mitochondrial
asset is testified by the constant increase in the content of mitochondrial DNA and protein (associated with increased expression of the transcription factor PGC1-α)
and is paralleled by the increase in the oxidative phosphorylation (Ox-Phos), while the level of glycolysis is unchanged. In p53-deficient myoblasts, by contrast, the
modulation of autophagy is greatly attenuated during the myogenesis process, mitogenesis is not induced and aggregates of abnormal mitochondria accumulate in
the cell. In these cells, the production of lactate and ATP increases during the differentiation of myoblasts up to the formation of myotubes, indicating that their
energetic metabolism relies essentially on glycolysis.
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it has been shown that, under starvation, FoxO activation,
promotes the synthesis of glutamine, which in turn prevents
the activation of mTOR and stimulates the autophagic flux
(Van Der Vos et al., 2012). On the other hand, p53 has
been shown to enhance mitochondrial respiration and ATP
generation and to increase the cellular level of anti-oxidant
GSH by promoting mitochondrial glutaminolysis (Hu et al.,
2010).
A better understanding of the gene networks operating during
muscle differentiation may open new avenues for the therapies of
muscle disorders and repair.
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